Sign Up Today and Learn More About Splice Bio Stock
Invest in or calculate the value of your shares in Splice Bio or other pre-IPO companies through EquityZen's platform.
Splice Bio Stock
Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.
About Splice Bio Stock
Founded
2012
Industries
Software, Artificial Intelligence, Data and Analytics
Splice Bio Press Mentions
Stay in the know about the latest news on Splice Bio
Startup Investment in Spain Stabilizes at €3.1 Billion in 2025 with Record Activity Levels
capital-riesgo • Jan 16, 2026
SpliceBio Initiates Dose-Expansion Portion of Phase 1/2 ASTRA Clinical Trial for SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
businesswire • Jan 09, 2026
SpliceBio Appoints Don Munoz as Chief Financial Officer
businesswire • Jan 06, 2026
Raising money in uncertain times: how Splice Bio secured $135 million for its gene therapy play
podcast • Oct 04, 2025
Budget blues: where are cell and gene therapies heading?
labiotech • Sep 18, 2025
Splice Bio Management
Leadership team at Splice Bio
Board Member
Erica Whittaker
Board Member
Marc Montserrat
Join now and verify your accreditation status to gain access to:
- Splice Bio Current Valuation
- Splice Bio Stock Price
- Splice Bio Management
- Available deals in Splice Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Splice Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Splice Bio Revenue and Financials
- Splice Bio Highlights
- Splice Bio Business Model
- Splice Bio Risk Factors
- Splice Bio Research Report from SACRA Research
Trading Splice Bio Stock
How to invest in Splice Bio stock?
Accredited investors can buy pre-IPO stock in companies like Splice Bio through EquityZen funds. These investments are made available by existing Splice Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Splice Bio stock?
Shareholders can sell their Splice Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."